Cargando…
No Mortality Difference Following Treatment with Terlipressin or Somatostatin in Cirrhotic Patients with Gastric Variceal Hemorrhage
BACKGROUND/AIMS: The aim of this study was to compare the efficacy of terlipressin versus somatostatin as adjuvants to endoscopic treatment in cirrhotic patients with gastric variceal bleeding. PATIENTS AND METHODS: The National Health Insurance Database, derived from the Taiwan National Health Insu...
Autores principales: | Hung, Tsung-Hsing, Tsai, Chen-Chi, Tseng, Kuo-Chih, Hsieh, Yu-Hsi, Tseng, Chih-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898092/ https://www.ncbi.nlm.nih.gov/pubmed/27184641 http://dx.doi.org/10.4103/1319-3767.182458 |
Ejemplares similares
-
No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment
por: Hung, Tsung-Hsing, et al.
Publicado: (2016) -
High mortality of pneumonia in cirrhotic patients with ascites
por: Hung, Tsung-Hsing, et al.
Publicado: (2013) -
High Mortality of Cirrhotic Patients With End-Stage Renal Disease
por: Hung, Tsung-Hsing, et al.
Publicado: (2016) -
Effect of Renal Function Impairment on the Mortality of Cirrhotic Patients With Hepatic Encephalopathy: A Population-Based 3-Year Follow-Up Study
por: Hung, Tsung-Hsing, et al.
Publicado: (2014) -
The long-term outcomes of cirrhotic patients with pleural effusion
por: Hung, Tsung-Hsing, et al.
Publicado: (2018)